drugset / Trial / NCT02116010

Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients

NCT02116010

Phase 1/2 Unknown Phagenix
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of PHAGOBURN is to assess tolerance and efficacy of local bacteriophage treatment of E. coli or P. aeruginosa wound infections in burned patients.

Timeline

Start
2015-07
Primary completion
2016-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject E. coli Phages cocktail Other / unclassified
Subject PP1131 Other / unclassified 100 unknown Topical
Comparator Silver Sulfadiazine Small molecule 1 % Topical

Indications